Clinical Study
Pro- and Antiapoptotic Markers in Upper Tract Urothelial Carcinoma
Associated with Balkan Endemic Nephropathy
Table 2
Association of proapoptotic biomarkers expression with pathological characteristics of UTUC.
| UUC | | Altered expression of biomarker | Bax | | Fas | | Casp3 index* | |
| Low grade | | | N.S. | | N.S. | | N.S | BEN | 16 | 9 | | 7 | | 6.7 ± 15.8 | | Control | 25 | 16 | | 8 | | 2 ± 5.3 | |
| High grade | | | 0.05 | | N.S. | | N.S. | BEN | 28 | 11 | | 16 | | 1.7 ± 2.7 | | Control | 36 | 25 | | 14 | | 1.7 ± 4.6 | |
| Low stage | | | N.S. | | N.S. | | N.S. | BEN | 17 | 10 | | 9 | | 2.9 ± 7.5 | | Control | 19 | 14 | | 7 | | 2.6 ± 6.7 | |
| High stage | | | 0.05 | | N.S. | | N.S. | BEN | 27 | 10 | | 14 | | 3.9 ± 11.2 | | Control | 42 | 27 | | 15 | | 1.5 ± 3.9 | |
| Papillary growth | | | N.S. | | N.S. | | N.S. | BEN | 12 | 4 | | 3 | | 4.2 ± 8.8 | | Control | 27 | 18 | | 8 | | 3.2 ± 7.1 | |
| Solid growth | | | N.S. | | N.S. | | N.S. | BEN | 32 | 16 | | 20 | | 3.2 ± 10.4 | | Control | 34 | 23 | | 14 | | 0.8 ± 1 | |
| LV invasion: yes | | | N.S. | | N.S. | | N.S. | BEN | 10 | 4 | | 6 | | 7 ± 17.9 | | Control | 20 | 15 | | 7 | | 1 ± 1.3 | |
| Necrosis: yes | | | 0.05 | | N.S. | | N.S. | BEN | 19 | 7 | | 10 | | 1.9 ± 2.8 | | Control | 25 | 17 | | 11 | | 1 ± 1 | |
| Nonmetaplastic | | | 0.05 | | 0.05 | | N.S. | BEN | 34 | 16 | | 17 | | 3.6 ± 11.1 | | Control | 48 | 33 | | 12 | | 1.7 ± 4.3 | |
| Metaplastic | | | N.S. | | N.S. | | | BEN | 10 | 4 | | 6 | | 3.2 ± 4 | | Control | 13 | 8 | | 10 | | 2.6 ± 6.8 | |
|
|
χ 2 test was performed.
*Mann Whitney U test was performed. N.S.: no significance.
|